Comparison of Gene Expression Profiling in Sarcomas and Mesenchymal Stem Cells Identifies Tumorigenic Pathways in Chemically Induced Rat Sarcoma Model

Mesenchymal stem cells (MSCs) are believed to be the cell of origin for most sarcomas including osteosarcoma and malignant fibrous histiocytoma (MFH/UPS). To identify the signaling pathways involved in sarcoma pathogenesis, we compared gene expression profiles in rat osteosarcoma and MFH cells with those in syngeneic rat MSCs. Analysis of genes that characterize MSCs such as CD44, CD105, CD73, and CD90 showed higher expression in MSCs compared to sarcomas. Pathways involved in focal and cell adhesion, cytokine-cytokine receptors, extracellular matrix receptors, chemokines, and Wnt signaling were down-regulated in both sarcomas. Meanwhile, DNA replication, cell cycle, mismatch repair, Hedgehog signaling, and metabolic pathways were upregulated in both sarcomas. Downregulation of p21Cip1 and higher expression of CDK4-cyclinD1 and CDK2-cyclinE could accelerate cell cycle in sarcomas. The current study indicated that these rat sarcomas could be a good model for their human counterparts and will provide the further insights into the molecular pathways and mechanisms involved in sarcoma pathogenesis.

[1]  A. Cleton-Jansen,et al.  Inactive Wnt/β‐catenin pathway in conventional high‐grade osteosarcoma , 2010, The Journal of pathology.

[2]  J. Paramio,et al.  Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo. , 2010, Cancer research.

[3]  R. Vento,et al.  Identification and expansion of human osteosarcoma‐cancer‐stem cells by long‐term 3‐aminobenzamide treatment , 2009, Journal of cellular physiology.

[4]  Edward W Scott,et al.  Stem-like cells in bone sarcomas: implications for tumorigenesis. , 2005, Neoplasia.

[5]  S. Aaronson,et al.  High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/β-catenin target gene, CDC25A. , 2011, Cancer cell.

[6]  Tsutomu Ohta,et al.  Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma , 2007, Modern Pathology.

[7]  M. Katoh,et al.  WNT Signaling Pathway and Stem Cell Signaling Network , 2007, Clinical Cancer Research.

[8]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[9]  Nobuyuki Tanaka,et al.  Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2 , 2008, Proceedings of the National Academy of Sciences.

[10]  M. Tsutsumi,et al.  Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas. , 1993, Cancer research.

[11]  D. Ornitz,et al.  Sequential roles of Hedgehog and Wnt signaling in osteoblast development , 2004, Development.

[12]  A. Look,et al.  Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. , 1993, Cancer research.

[13]  F. Mertens,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .

[14]  A. McMahon,et al.  Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors , 2006, Development.

[15]  T. Kawabe,et al.  p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. , 2005, Cancer research.

[16]  W. Birchmeier,et al.  Wnt signalling and its impact on development and cancer , 2008, Nature Reviews Cancer.

[17]  A. Cleton-Jansen,et al.  Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2 , 2009, The Journal of pathology.

[18]  X. Zi,et al.  The Wnt signaling pathway: implications for therapy in osteosarcoma , 2011, Expert review of anticancer therapy.

[19]  H. Ohgushi,et al.  Bone marrow‐derived mesenchymal cells can rescue osteogenic capacity of devitalized autologous bone , 2008, Journal of tissue engineering and regenerative medicine.

[20]  E. Epstein.  Basal cell carcinomas: attack of the hedgehog , 2008, Nature Reviews Cancer.

[21]  D. Prockop,et al.  The Wnt Signaling Inhibitor Dickkopf-1 Is Required for Reentry into the Cell Cycle of Human Adult Stem Cells from Bone Marrow* , 2003, Journal of Biological Chemistry.

[22]  M. Kay,et al.  Sarcoma Derived from Cultured Mesenchymal Stem Cells , 2007, Stem cells.

[23]  R. Cancedda,et al.  Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds. , 2009, Carcinogenesis.

[24]  S. Okazaki,et al.  Transformation potential of bone marrow stromal cells into undifferentiated high-grade pleomorphic sarcoma , 2010, Journal of Cancer Research and Clinical Oncology.

[25]  N. Socci,et al.  Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. , 2007, The Journal of clinical investigation.

[26]  G. Wei,et al.  CDK4 gene amplification in osteosarcoma: Reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons , 1999, International journal of cancer.

[27]  R. Nusse,et al.  Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context , 2006, PLoS biology.

[28]  J. Lees,et al.  Rb regulates fate choice and lineage commitment in vivo , 2010, Nature.

[29]  Y. Konishi,et al.  Heterogeneous pattern of gene expression in cloned cell lines established from a rat transplantable osteosarcoma lung metastatic nodule. , 1998, Cancer letters.

[30]  T. Curran,et al.  Loss of suppressor-of-fused function promotes tumorigenesis , 2007, Oncogene.

[31]  C. Cavaliere,et al.  Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours , 2008, PloS one.

[32]  C. Fletcher.  The evolving classification of soft tissue tumours: an update based on the new WHO classification , 2006, Histopathology.

[33]  N. Cordani,et al.  Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts. , 2003, International journal of oncology.

[34]  A. Trumpp,et al.  Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. , 2005, Cancer research.

[35]  I. Judson.  State-of-the-art approach in selective curable tumours: soft tissue sarcoma. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  J. Aubin,et al.  Osteoblast and chondroblast differentiation. , 1995, Bone.

[37]  T. Takizawa,et al.  Role of GLI2 in the growth of human osteosarcoma , 2011, The Journal of pathology.